- Tether has invested $200 million in brain chipmaker Blackrock Neurotech, making it its largest shareholder.
- Blackrock Neurotech develops brain-computer interfaces that show great potential for application in human life.
- Through its investment arm, Tether Evo, Tether is committed to advancing the convergence of technology and human capabilities and accelerating its growth in the high-tech sector.
Cryptocurrency company Tether has announced a significant $200 million investment in Blackrock Neurotech, a manufacturer of brain-computer interfaces, a move that not only signals the company’s expansion into the advanced technology sector but also signals the future of a deeper convergence between technology and human life.
Also read: Tether partners with Celo network to expand USDT distribution
Transaction details and objectives
Tether corporation has announced the completion of a $200 million investment in Blackrock Neurotech, a US-based brain chipmaker, through which Tether becomes the company’s largest shareholder.
Tether CEO Paul Aldoino said that the transaction was completed as a result of months of due diligence and that Blackrock Neurotech’s market capitalisation is currently around $350 million.
The funds invested will be used primarily for the commercialisation and rollout of Blackrock Neurotech’s technology.
Also read: UK fintech TransferGo secures $10M investment, eyeing expansion
Tether’s investment strategy and market outlook
Tether is one of the world’s leading cryptocurrency companies, known for its issuance of stablecoins pegged to the US dollar. The company’s rapid growth in recent years has led it to reach a staggering $100 billion in liquidity in March.
Aldoino revealed that Tether has made around $1.7bn in venture capital investments using its profit funds, covering a variety of sectors including sustainable energy, artificial intelligence, and peer-to-peer technology.
Tether’s investment arm, Tether Evo, was created to drive the convergence of technology and human capabilities, and this investment in Blackrock Neurotech is part of its strategy.
